News Type:

New article provides insights into immediate vaccine hypersensitivity reactions 11th July 2023

An article published in the Journal of Allergy and Clinical Immunology this month sheds new light on the management of immediate hypersensitivity reactions to vaccines.  

Read more
The ability of children and families with and without nut allergy to correctly identify nuts 10th July 2023

Researchers assessed nut recognition in children with and without nut allergy and their parents or guardians.

Read more
New feeding guidelines for children aged 1-5 reinforce importance of early introduction and continued consumption 6th July 2023

SACN has released a report that reviews the current recommendations for feeding children aged 1 to 5 years.

Read more
Significant Drop in Allergen-Related Product Recalls in Australia 29th June 2023

A recent report by Food Standards Australia New Zealand (FSANZ) has revealed that last year, Australia had their lowest rate of allergen-related product recalls in almost a decade. This reduction suggests that FSANZ’s initiatives and tighter regulations in the food

Read more
Allergy dad completes 35-mile ultra marathon in support of Anaphylaxis UK 28th June 2023

Avid runner and allergy dad Luke Taylor completed the ultra marathon from Sheffield to Nottingham, covering a distance of 35 miles in just over seven hours, in aid of Anaphylaxis UK.

Read more
Statement on the death of Eamonn Hogan 28th June 2023

Anaphylaxis UK recently learned of the tragic death of Eamonn Hogan, aged 43, from Kilcoo, Northern Ireland.  Eamonn suffered a serious and unexpected anaphylactic reaction to a wasp sting on Tuesday 13th June.

Read more
MHRA issues new guidance on the use of adrenaline auto-injectors 19th June 2023

The Medicines and Healthcare products Regulatory Agency (MHRA) has launched new guidance on the use of adrenaline auto-injectors, including what steps to take in an emergency and updated advice on body positioning.

Read more
Patients at risk from anaphylaxis to benefit from new GP guidance 15th June 2023

The British Society for Allergy and Clinical Immunology (BSACI) has announced the publication of the Adrenaline auto-injector prescription for patients at risk of anaphylaxis: BSACI guidance for primary care. The guidance, written by the BSACI, is for primary care healthcare professionals managing

Read more
MHRA issues clarification on use of spare pens in schools 12th June 2023

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued clarification on when schools’ spare adrenaline auto-injectors can be used.

Read more